MLVA-ompA genotypes according to HIV status
| ompA | MLVA* | HIV positive (Chlamydia trachomatis positives (n)) | HIV negative (C. trachomatis positives (n)) |
|---|---|---|---|
| D/IC-CAL8† | 3.6.4 | 1 | |
| 3.8.1 | 1 | ||
| 6.13.3 | 1 | ||
| 8.5.1 | 3 | ||
| 8.6.4 | 1 | ||
| 8.6.5 | 1 | ||
| 8.7.2 | 1 | ||
| 8.8.1 | 1 | ||
| 8.8.3 | 1 | ||
| 14.7.3 | 1 | ||
| D/UW-3/CX† | 3.6.4 | 1 | |
| 8.2.4 | 1 | ||
| 8.4.1 | 1 | ||
| 8.6.1 | 1 | ||
| 8.6.3 | 1 | ||
| E | 3.7.2 | 1 | |
| 8.2.1 | 1 | ||
| 8.3.1 | 1 | ||
| 8.3.2 | 1 | ||
| 8.5.1 | 1 | 4 | |
| 8.5.3 | 1 | 1 | |
| 8.6.1 | 1 | ||
| 8.7.1 | 1 | 2 | |
| 8.7.2 | 1 | ||
| 8.7.4 | 1 | 1 | |
| 8.9.1 | 1 | ||
| 8.9.3 | 1 | ||
| F | 8.2.4 | 1 | |
| 8.4.5 | 1 | ||
| 8.5.1 | 2 | 1 | |
| 8.7.3 | 1 | ||
| 8.8.2 | 1 | ||
| G | 1.3.3 | 1 | |
| 2.5.3 | 1 | ||
| 2.5.4 | 1 | ||
| 2.11.4 | 1 | ||
| 3.2.4 | 1 | ||
| 3.3.3 | 1 | ||
| 3.4.3 | 1 | 1 | |
| 3.5.3 | 1 | ||
| 3.6.3 | 2 | ||
| 3.6.4 | 1 | ||
| 3.7.3 | 3 | ||
| 8.5.1 | 1 | ||
| 8.5.2 | 1 | ||
| 8.5.4 | 1 | ||
| 8.5.5 | 2 | ||
| 8.6.2 | 1 | ||
| 8.6.3 | 1 | ||
| I | 8.7.5 | 1 | |
| J | 1.6.3 | 1 | |
| 2.7.3 | 1 | ||
| 3.2.4 | 1 | ||
| 3.5.2 | 1 | ||
| 3.5.3 | 1 | ||
| 8.3.4 | 1 | ||
| 8.9.2 | 1 | ||
| L2 | 1.9.4 | 1 | |
| 8.5.5 | 1 | ||
| L2b | 1.5.2 | 1 | |
| 1.5.3 | 1 | ||
| 1.9.1 | 1 | ||
| 1.9.2 | 1 | 2 | |
| 3.5.2 | 1 | ||
| 8.5.4 | 1 | ||
| 8.5.5 | 1 |
*MLVA genotype is designated in order of loci: CT1335, CT1299 and CT1291.
†ompA genotype D is subdivided into D/IC-CAL8 and D/UW-3/CX.
MLVA-ompA, multilocus variable number tandem repeat analysis plus analysis of the ompA gene.